173 related articles for article (PubMed ID: 15740732)
1. Effect of zelandopam, a dopamine D1-like receptor agonist, in puromycin aminonucleoside nephrosis rats.
Yatsu T; Aoki M; Tanaka A
Eur J Pharmacol; 2005 Mar; 510(1-2):121-6. PubMed ID: 15740732
[TBL] [Abstract][Full Text] [Related]
2. Renoprotective effect of the L/N-type calcium channel antagonist cilnidipine on puromycin aminonucleoside-induced nephrosis in rats.
Takashima K; Nishiyama C; Arisaka N; Takahashi T; Souma S; Tsuda M; Hayashi M; Kasahara H; Kodama H; Tamura T; Murakami M; Kuroda J; Sato F
Arzneimittelforschung; 2009; 59(2):79-85. PubMed ID: 19338138
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
Schwartz MM; Sharon Z; Pauli BU; Lewis EJ
Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977
[TBL] [Abstract][Full Text] [Related]
4. Effect of captopril on chronic puromycin aminonucleoside nephrosis in rats.
Radin MJ; Wilke WL; Fettman MJ
Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):279-82. PubMed ID: 3538253
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis.
Kokui K; Yoshikawa N; Nakamura H; Itoh H
J Pathol; 1992 Mar; 166(3):297-301. PubMed ID: 1517884
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
[TBL] [Abstract][Full Text] [Related]
7. [Effects of human Cu, Zn-superoxide dismutase in aminonucleoside nephrosis--evaluation of the morphology and glomerular basement membrane anionic charge sites].
Higuchi A
Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):767-75. PubMed ID: 2273594
[TBL] [Abstract][Full Text] [Related]
8. Preventive effect of zelandopam, a dopamine D1 receptor agonist, on cisplatin-induced acute renal failure in rats.
Yatsu T; Aoki M; Inagaki O
Eur J Pharmacol; 2003 Feb; 461(2-3):191-5. PubMed ID: 12586214
[TBL] [Abstract][Full Text] [Related]
9. [Effects of FK506 on aminonucleoside-induced nephrotic rats].
Kawaguchi S
Nihon Jinzo Gakkai Shi; 1992 Feb; 34(2):141-51. PubMed ID: 1375300
[TBL] [Abstract][Full Text] [Related]
10. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
Yamashita J; Nakajima K; Ohno Y; Kaneshiro Y; Matsuo T; Tanaka H; Kaneko K
Eur J Pharmacol; 2008 Jul; 589(1-3):239-44. PubMed ID: 18541230
[TBL] [Abstract][Full Text] [Related]
12. Time course of lipid peroxidation in puromycin aminonucleoside-induced nephropathy.
Fawcett JP; Jiang R; Walker RJ
Res Commun Mol Pathol Pharmacol; 1994 Nov; 86(2):227-34. PubMed ID: 7881871
[TBL] [Abstract][Full Text] [Related]
13. Experimental nephrosis: interassociation of proteinuria with impaired lymphocyte blastogenesis.
Minchin MA; Bower GD; Turner KJ
Clin Exp Immunol; 1981 Feb; 43(2):270-5. PubMed ID: 7273481
[TBL] [Abstract][Full Text] [Related]
14. Steroids and Adriamycin nephrosis.
Bertani T; Remuzzi G; Rocchi G; Delaini F; Sacchi G; Falchetti M; Donati MB
Appl Pathol; 1984; 2(1):32-8. PubMed ID: 6525317
[TBL] [Abstract][Full Text] [Related]
15. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
[TBL] [Abstract][Full Text] [Related]
16. Studies on the effectiveness of sairei-to on puromycin aminonucleoside nephrosis in rats.
Joarder ZH; Ogawa T; Yorioka N; Yamakido M
Hiroshima J Med Sci; 1991 Dec; 40(4):127-35. PubMed ID: 1797743
[TBL] [Abstract][Full Text] [Related]
17. DMSO potentiates aminonucleoside of puromycin nephrosis in rats.
Spear GS; Nguyen D; Conklin S; Wikle JS; Fan J; Lan YH; Allen J; Reineck S
J Pathol; 1987 Oct; 153(2):183-7. PubMed ID: 3694323
[TBL] [Abstract][Full Text] [Related]
18. Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat.
Holthöfer H; Reivinen J; Solin ML; Haltia A; Miettinen A
Am J Pathol; 1996 Sep; 149(3):1009-15. PubMed ID: 8780404
[TBL] [Abstract][Full Text] [Related]
19. Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome.
Sampaio-Maia B; Moreira-Rodrigues M; Serrão P; Pestana M
Nephrol Dial Transplant; 2006 Feb; 21(2):314-23. PubMed ID: 16204272
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D1-like receptors agonist SKF 38393 increases cFOS expression in the paraventricular nucleus of the hypothalamus--impact of acute and chronic cocaine.
Chocyk A; Czyrak A; Wedzony K
J Physiol Pharmacol; 2008 Sep; 59(3):425-40. PubMed ID: 18953088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
